WORKING IN PRACTICES WITH CONTRASTING POPULATION NEEDS AND ALTERNATIVE FUNDING MODELS GP runs population relay between practices
People In Health Care Series
Dr Jaspreet Saini, GP
Clinic Director, Healthicare &
Practice Owner and Principal GP, Rosedale Medical Practice
Filmed in Rooty Hill, New South Wales | October 2024
Dr Jaspreet Saini is a GP with a decade of experience, practicing in West Pennant Hills and Rooty Hill, New South Wales. He began his medical journey at Monash University, followed by internships and residency at Blacktown Hospital, in Western Sydney. Instead of confining himself to a single specialty, he pursued general practice to explore various facets of medicine.
His career philosophy centres around addressing frustrations within the healthcare system and advocating for multidisciplinary care. This commitment led him to travel to the United States, where he studied diverse healthcare models, particularly in underserved areas. Recognising the potential for improving primary care in Australia, he and his wife purchased a practice in West Pennant Hills in 2019, which has since received multiple awards for its innovative care approach.
However, Dr Saini felt a strong urge to work in a more underserved community to tackle health equity issues. He has been actively involved in a clinic in Rooty Hill since February 2024, focusing on redesigning healthcare delivery in an area characterised by socio-economic challenges and high rates of chronic conditions like obesity and diabetes.
His typical workweek has evolved to blend clinical practice with leadership and management. Three days a week, he coaches healthcare teams, guiding GPs, nurses, and medical assistants to enhance their clinical skills. Additionally, he engages in research related to health equity and models of care, seeking grants and writing papers.
Collaborative partnerships are pivotal to his approach. In Rooty Hill, his practice works closely with organisations like the Western Sydney Diabetes team, adopting proactive strategies to manage patients’ chronic conditions effectively. Through teamwork, they aim to provide holistic and efficient care, recognising that silos within healthcare hinder optimal outcomes.
-
Clinical pain neuroscientist talks about how the brain processes pain information
Persistent pain affects one in five Australians and costs the nation an estimated $73 billion per year in health system costs, lost productivity and other financial costs.
Persistent pain also has debilitating personal costs – negatively impacting quality of life and the ability to engage in meaningful work and life activities.
Despite the enormity of this problem, very few effective treatments exist with most showing only small to moderate improvements. New treatments are desperately needed. The group believes the best way to create impactful change is to work with people with lived experience of persistent pain to devise solutions with them, not for them.
-
The desire for primary care nurses to do more, be recognised and valued for the work they do
Denise Lyons is a highly experienced nurse with over 40 years in the profession, including more than 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centred care that improves the health and wellbeing of her community.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
